Publication | Open Access
Phase I Trial of Cixutumumab Combined with Temsirolimus in Patients with Advanced Cancer
116
Citations
13
References
2011
Year
Temsirolimus combined with cixutumumab was well tolerated. We are currently enrolling expansion cohorts at the MTD for Ewing's sarcoma and adrenocortical carcinoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1